Showing 3 of 3 recruiting trials for “Lymphoepithelial-like carcinoma”
Safety and Efficacy of Pucotenlimab in pLECC
Testing the Addition of an Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery to the Usual Surgery Alone for Treating Advanced Skin Cancer
RecruitingNCT06801977 ↗
The Chinese Pulmonary Lymphoepithelioma-like Carcinoma Collaboration Study
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →